Table 8.

Disease progress and outcome of treatment data in a probable or confirmed case of COVID-19

Main class	Sub class	Data element
Admission to hospital	Hospitalization	Need for hospitalization, first date of admission to hospital, discharge date, discharge status, hospital name, hospital type, hospital ID/code
	Care in an intensive care unit	Receive care in an intensive care unit, Length of stay (LOS) in ICU
	Receive ventilation and intubation	Receive mechanical ventilation, the number of ventilator days, need to intubation, the number of intubation days
OVID-19 Medications	The main medications prescribed	Date, chloroquine phosphate, hydroxychloroquine, kaletra (lopinavir/ritonavir), ribavirin, remdesivir, avipiravir, oseltamivir (tamiflu), Atazanavir/ritonavir, plasma transfusion, other(s), please specify, additional comment
	The auxiliary medications prescribed	Date, naproxen, azithromycin, IVIG, sofosbuvir/daclatasvir (Sovodak), other(s), please specify, additional comment
Disease complications and outcome	Systemic complications	Sepsis/septic shock, multisystem inflammatory syndrome in children (MIS-C), multiorgan failure, cytokine release syndrome, acute kidney injury (AKI), acute liver injury, hepatitis
	Respiratory complications	Pneumonia, ‏acute respiratory distress syndrome (ARDS), respiratory failure
	Cardiovascular complications	Myocardial infarction, heart failure, arrhythmias, acute coronary syndrome, endothelialitis, vasculitis, viral myocarditis, other cardiovascular complications
	Hematologic complications	Disseminated intravascular coagulation (DIC), thrombocytopenia, leukocytosis, leukocytopenia, pulmonary embolism (PE), deep vein thrombosis (DVT)
	Neurologic complications	Cerebrovascular accident (CVA), meningitis, encephalopathy, other neurologic complications
	Other complications	Date, the name of complications, additional comment
	Outcome	Recovered/healthy, death, not recovered, other(s), please specify